7th Oct 2011 13:14
Block Listing Six Monthly Return
Information provided on this form must be typed or printed electronically and provided to an RIS.
Date: 7 October 2011
Name of applicant: | Hikma Pharmaceuticals PLC | |||
Name of scheme: | Hikma Pharmaceuticals PLC 2004 Stock Option Plan ("SOP") & Hikma Pharmaceuticals PLC 2005 Long-Term Incentive Plan ("LTIP") | |||
Period of return | From: | 1 April 2011 | To: | 1 October 2011 |
Balance of unallotted securities under scheme(s) from previous return: | SOP: 3,045,118 ordinary shares of 10 pence each LTIP: 700,000 ordinary shares of 10 pence each | |||
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | SOP: 0 ordinary shares of 10 pence each LTIP: 0 ordinary shares of 10 pence each | |||
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | SOP: 1,050,818 ordinary shares of 10 pence each LTIP: 700,000 ordinary shares of 10 pence each | |||
Equals: Balance under scheme(s) not yet issued/allotted at end of period: | SOP: 1,994,300 ordinary shares of 10 pence each LTIP: 0 ordinary shares of 10 pence each | |||
Name of contact: | Peter Speirs |
Telephone number of contact: | 0207 399 2772 |
Long Term Incentive Plan ("LTIP") | ||||
Date | Block Listing | Shares Issued | Balance (Headroom) | Notes |
22/04/2011 | 0 | 700,000 | 0 | Shares were issued to EBT. |
Stock Option Plan ("SOP") | ||||
Date | Block Listing | Shares Issued | Balance (Headroom) | Notes |
07/04/2011 | 0 | 3,600 | 3,041,518 | |
07/04/2011 | 0 | 20,072 | 3,021,446 | |
07/04/2011 | 0 | 236,346 | 2,785,100 | |
15/04/2011 | 0 | 2,000 | 2,783,100 | |
21/04/2011 | 0 | 3,400 | 2,779,700 | |
21/04/2011 | 0 | 1,200 | 2,778,500 | |
05/05/2011 | 0 | 300,000 | 2,478,500 | |
06/05/2011 | 0 | 1,700 | 2,476,800 | |
06/05/2011 | 0 | 2,500 | 2,474,300 | |
06/05/2011 | 0 | 10,800 | 2,463,500 | |
06/05/2011 | 0 | 2,500 | 2,461,000 | |
06/05/2011 | 0 | 3,500 | 2,457,500 | |
06/05/2011 | 0 | 5,400 | 2,452,100 | |
13/05/2011 | 0 | 1,700 | 2,450,400 | |
13/05/2011 | 0 | 1,700 | 2,448,700 | |
13/05/2011 | 0 | 2,500 | 2,446,200 | |
13/05/2011 | 0 | 2,500 | 2,443,700 | |
13/05/2011 | 0 | 2,500 | 2,441,200 | |
13/05/2011 | 0 | 1,700 | 2,439,500 | |
13/05/2011 | 0 | 2,500 | 2,437,000 | |
13/05/2011 | 0 | 2,500 | 2,434,500 | |
13/05/2011 | 0 | 2,800 | 2,431,700 | |
13/05/2011 | 0 | 1,700 | 2,430,000 | |
20/05/2011 | 0 | 2,000 | 2,428,000 | |
20/05/2011 | 0 | 1,700 | 2,426,300 | |
20/05/2011 | 0 | 2,500 | 2,423,800 | |
27/05/2011 | 0 | 1,700 | 2,422,100 | |
27/05/2011 | 0 | 1,700 | 2,420,400 | |
27/05/2011 | 0 | 2,500 | 2,417,900 | |
03/09/2011 | 0 | 3,600 | 2,414,300 | |
10/06/2011 | 0 | 400,000 | 2,014,300 | |
10/06/2011 | 0 | 17,500 | 1,996,800 | |
24/06/2011 | 0 | 2,500 | 1,994,300 | |
Related Shares:
Hikma Pharmaceuticals